Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Wednesday.
Kewaunee Scientific Price Performance
Shares of NASDAQ:KEQU traded down $0.72 during midday trading on Wednesday, reaching $53.03. 13,103 shares of the company's stock were exchanged, compared to its average volume of 17,233. The company's 50 day simple moving average is $38.92 and its two-hundred day simple moving average is $42.40. The firm has a market capitalization of $152.30 million, a PE ratio of 8.40 and a beta of 0.80. Kewaunee Scientific has a 12 month low of $24.49 and a 12 month high of $56.95. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53.
Insider Transactions at Kewaunee Scientific
In related news, VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares of the company's stock, valued at $736,224.47. This trade represents a 11.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.20% of the stock is owned by insiders.
Institutional Investors Weigh In On Kewaunee Scientific
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC acquired a new stake in Kewaunee Scientific in the 3rd quarter valued at about $121,000. Heron Bay Capital Management acquired a new stake in Kewaunee Scientific in the 2nd quarter valued at about $252,000. State Street Corp acquired a new stake in Kewaunee Scientific in the 3rd quarter valued at about $266,000. Ritholtz Wealth Management increased its position in Kewaunee Scientific by 24.6% in the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock valued at $363,000 after acquiring an additional 2,156 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after acquiring an additional 1,941 shares in the last quarter. Institutional investors and hedge funds own 32.69% of the company's stock.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
